Aclaris Therapeutics, Inc.
ACRSNasdaqCIK 1557746HealthcareFiscal year ends Dec 31
Reports and events: 230 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2717:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-119231 |
| 2026-10-2706:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-118952 |
| 2026-08-0617:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-092128 |
| 2026-08-0616:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-092065 |
| 2026-08-0607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091629 |
| 2026-06-0416:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-070494 |
| 2026-05-0716:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057202 |
| 2026-05-0707:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-056669 |
| 2026-04-2806:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-049733 |
| 2026-04-2307:45 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001104659-26-047262 |
| 2026-03-1116:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-26-026407 |
| 2026-03-1021:51 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-26-025420 |
| 2026-02-2616:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-020540 |
| 2026-02-2607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-020070 |
| 2026-01-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002694 |
| 2026-01-0607:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-001076 |
| 2025-11-0616:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107788 |
| 2025-11-0607:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107353 |
| 2025-10-1406:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-098991 |
| 2025-08-0716:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010789 |
| 2025-08-0707:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010640 |
| 2025-07-2916:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-009739 |
| 2025-06-3006:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008984 |
| 2025-06-0516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008430 |
| 2025-05-0816:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006993 |
| 2025-05-0807:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006851 |
| 2025-04-2407:00 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001558370-25-005332 |
| 2025-02-2716:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001819 |
| 2025-02-2707:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-001679 |
| 2025-01-1307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000148 |
| 2024-11-1808:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-015838 |
| 2024-11-0616:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014646 |
| 2024-11-0607:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014522 |
| 2024-08-0716:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011376 |
| 2024-08-0707:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011201 |
| 2024-07-1616:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-009853 |
| 2024-06-0716:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-009009 |
| 2024-05-0716:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007069 |
| 2024-05-0716:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-007055 |
| 2024-04-2507:00 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001558370-24-005677 |
| 2024-03-1916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-24-003572 |
| 2024-02-2707:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-001753 |
| 2024-02-2707:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-001752 |
| 2024-02-0516:31 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001558370-24-000770 |
| 2024-02-0516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-24-000769 |
| 2024-01-1907:30 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-000373 |
| 2023-12-1916:15 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-019911 |
| 2023-11-1307:42 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-018691 |
| 2023-11-0607:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017660 |
| 2023-11-0607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-017655 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.